Immune responses induced by T-cell vaccination in patients with rheumatoid arthritis

References

• Stamenkovic I, Stegagno M, Wright KA, Krane SM, Amento EP, Colvin RB, Duquesnoy RJ, Kurnick JT. Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A 1988; 85:1179 - 83; http://dx.doi.org/10.1073/pnas.85.4.1179; PMID: 2963340
   PubMed Web of Science ®Google Scholar
• VanderBorght A, Geusens P, Raus J, Stinissen P. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 2001; 31:160 - 75; http://dx.doi.org/10.1053/sarh.2001.27736; PMID: 11740797
   PubMed Web of Science ®Google Scholar
• Fekete A, Soos L, Szekanecz Z, Szabo Z, Szodoray P, Barath S, Lakos G. Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. J Autoimmun 2007; 29:154 - 63; http://dx.doi.org/10.1016/j.jaut.2007.07.002; PMID: 17826949
   PubMed Web of Science ®Google Scholar
• Correale J, Farez M, Gilmore W. Vaccines for multiple sclerosis: progress to date. CNS Drugs 2008; 22:175 - 98; http://dx.doi.org/10.2165/00023210-200822030-00001; PMID: 18278975
   PubMed Web of Science ®Google Scholar
• Honda A, Ametani A, Matsumoto T, Iwaya A, Kano H, Hachimura S, Ohkawa K, Kaminogawa S, Suzuki K, Sercarz EE, et al. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis. Int Immunol 2004; 16:737 - 45; http://dx.doi.org/10.1093/intimm/dxh075; PMID: 15096482
   PubMed Web of Science ®Google Scholar
• Moreland LW, Heck LW Jr., Koopman WJ, Saway PA, Adamson TC, Fronek Z, O’Connor RD, Morgan EE, Diveley JP, Richieri SP, et al. V β 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study. J Rheumatol 1996; 23:1353 - 62; PMID: 8856613
   PubMed Web of Science ®Google Scholar
• Zang YCQ, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, Zhang JZ. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol 2000; 30:908 - 13; http://dx.doi.org/10.1002/1521-4141(200003)30:3<908::AID-IMMU908>3.0.CO;2-1; PMID: 10741408
   PubMed Web of Science ®Google Scholar
• Vandenbark AA. TCR peptide vaccination in multiple sclerosis: Boosting a deficient natural regulatory network that may involve TCR-specific CD4+CD25+ Treg cells. Curr Drug Targets Inflamm Allergy 2005; 4:85 - 94; http://dx.doi.org/10.2174/1568010053586327; PMID: 15720241
   PubMedGoogle Scholar
• Hellings N, Raus J, Stinissen P. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action. Autoimmun Rev 2004; 3:267 - 75; http://dx.doi.org/10.1016/j.autrev.2003.10.002; PMID: 15246022
   PubMed Web of Science ®Google Scholar
• Hong J, Zang YCQ, Tejada-Simon MV, Li S, Rivera VM, Killian J, Zhang JZ. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol 2000; 165:6858 - 64; PMID: 11120809
   PubMed Web of Science ®Google Scholar
• Seledtsov DB, Seledtsov VI, Ivanova IP, Litvinova LS. Antigen-specific immunotherapy of multiple sclerosis. Cytokines and inflammation (Russia) 2010; 1:3 - 12
   Google Scholar
• Vandenbark AA, Morgan E, Bartholomew R, Bourdette D, Whitham R, Carlo D, Gold D, Hashim G, Offner H. TCR peptide therapy in human autoimmune diseases. Neurochem Res 2001; 26:713 - 30; http://dx.doi.org/10.1023/A:1010951706830; PMID: 11519731
   PubMed Web of Science ®Google Scholar
• Nanki T, Lipsky PE. Cytokine, activation marker, and chemokine receptor expression by individual CD4(+) memory T cells in rheumatoid arthritis synovium. Arthritis Res 2000; 2:415 - 23; http://dx.doi.org/10.1186/ar120; PMID: 11056676
   PubMedGoogle Scholar
• Seledtsov VI, Litvinova LS, Goncharov AG, Schupletsova VV, Seledtsov DV, Guzol AA, Seledtsova IA. Cellular mechanisms underlying generation of the immunological memory. Cytokines and Inflammation (Russia) 2010; 4:9 - 15
   Google Scholar
• Corthay A. How do regulatory T cells work?. Scand J Immunol 2009; 70:326 - 36; http://dx.doi.org/10.1111/j.1365-3083.2009.02308.x; PMID: 19751267
   PubMed Web of Science ®Google Scholar
• Seledtsov VI, Ivanova IP, Samarin DM, Kozlov VA. The technology for polyclonal T-cell vaccine development designed for treatment of immunological abnormalities. Patent No. 2277422, 10.06.2006, Russian Federation.
   Google Scholar
• Ivanova IP, Seledtsov VI, Banul NV, Samarin DM, Seledtsova GV, Savkin IV, Shirinsky VS, Pronkina NV, Kozlov VA. Preparation of T cell vaccine and its application in treating multiple sclerosis. Med Immunol 2005; 7:27 - 32
   Google Scholar
• Strom SC, Michalopoulos G. Collagen as a substrate for cell growth and differentiation. Methods Enzymol 1982; 82:Pt A 544 - 55; http://dx.doi.org/10.1016/0076-6879(82)82086-7; PMID: 7043209
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265 - 75; PMID: 14907713
   PubMed Web of Science ®Google Scholar
• Ivanova IP, Seledtsov VI, Seledtsov DV, Samarin DM, Seledtsova GV, Herzsog OA, Kozlov VA. Characterization of immunogenic properties of polyclonal T cell vaccine intended for the treatment of rheumatoid arthritis. Bull Exp Biol Med 2007; 144:630 - 4; http://dx.doi.org/10.1007/s10517-007-0391-5; PMID: 18642727
   PubMed Web of Science ®Google Scholar
• Fransen J, Stucki G, van Riel PLC. Rheumatoid arthritis measures. Arthr Rheum 2003; 49:214 - 24; http://dx.doi.org/10.1002/art.11407
   Google Scholar